Guidelines for treatment of anthrax [4] (multiple letters)

JAMA

Volumn 288, Issue 15, 2002, Pages 1848-1849

  Meyerhoff, Andrea ^a   Murphy, Dianne ^a   Tice, Alan D ^a   Inglesby, Thomas ^a   O'Toole, Tara ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; DOXYCYCLINE; PROCAINE PENICILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ANTIINFECTIVE AGENT;

ADULT; ANTHRAX; ANTIBIOTIC THERAPY; BACILLUS ANTHRACIS; BACTERIAL INFECTION; CHILD; FOOD AND DRUG ADMINISTRATION; HUMAN; INTERNET; LETTER; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; ANTIBIOTIC PROPHYLAXIS; BIOLOGICAL WARFARE; NOTE; RESPIRATORY TRACT INFECTION; UNITED STATES;

ANTHRAX; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BIOTERRORISM; HUMANS; RESPIRATORY TRACT INFECTIONS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 0037120817     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.288.15.1848     Document Type: Letter

References (0)